Concepedia

LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

Christos V. Rizos, Ioannis Skoumas, Lοukianos S. Rallidis, Emmanouil Skalidis, Anastasia Garoufi, Panagiotis Anagnostis, George Sfikas, Vasilios Kotsis, Genovefa Kolovou, Vaia Lambadiari,

International Journal of Cardiology · 2021 · 27 citations · 22 references

DOI

Concepts

References

22

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.9K citations · Full text

, , +17

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text

, , +17

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

Børge G. Nordestgaard, M. John Chapman, Steve E. Humphries et al. · European Heart Journal · 2013 · 2.7K citations · Full text

, , +17

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

Frederick E. Dewey, Viktoria Gusarova, Richard L. Dunbar et al. · New England Journal of Medicine · 2017 · 875 citations · Full text

, , +15

Efficacy of statins in familial hypercholesterolaemia: a long term cohort study

Jorie Versmissen, Daniëlla M. Oosterveer, Mojgan Yazdanpanah et al. · BMJ · 2008 · 719 citations · Full text

, , +17